Universal Health (UHS) Reports In-Line Q4 EPS; offers guidance

Universal Health (NYSE: UHS) reported Q4 EPS of $5.88, in-line with the analyst estimate of $5.88. Revenue for the quarter came in at $4.49 billion, versus $4.51 billion reported last year.

GUIDANCE:

Universal Health sees FY2026 EPS of $22.64-$24.52, versus the consensus of $23.39. Universal Health sees FY2026 revenue of $18.417-18.789 billion, versus the consensus of $18.244 billion.

For earnings history and earnings-related data on Universal Health (UHS) click here.

You May Also Be Interested In

• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• HII completes acceptance sea trials for carrier John F. Kennedy
• Applied Materials (AMAT) call put ratio 1 call to 1 put on 190K contracts